NOTOCORD has the honour to sponsor the 12th meeting "New frontiers in basic cardiovascular research: France - New EU members" which is organised on July 3-6, 2016 at the Faculty of Pharmacy, University Paris-Sud in Châtenay-Malabry, France.

The Symposium was initiated by Dr Philippe LAZAR, General Director of INSERM to make a scientific reunion among 3 countries France, Republic Czech and Slovakia in the cardiovascular domain, and now expands to several new EU members such as Poland, Hungary, not only East European countries but also Baltic countries. 

Konigsberg Instruments (ITS) announced its closure last October. Since then, NOTOCORD has continued to support all customers using such technology.

What is the future of telemetry in 2015 without this key player?

NOTOCORD wishes to reintroduce its two main partners: DSI and TSE (Stellar Telemetry), helping you perform your telemetry experiments while continuing to use NOTOCORD-hem. Data collected with DSI and Stellar Telemetry implants can be processed with NOTOCORD® modules for cardiovascular, neurology, and respiration studies.

Authors: Simon Authier (CiToxLAB North America), Abdel-Ilah El Amrani (CiToxLAB France) and Christina Skytte (CiToxLAB Denmark), Roy Forster (CiToxLAB France)

Quantification of QT has been a major safety consideration in the last decade in safety pharmacology.
As a surrogate for torsade de pointe, QT prolongation remains a central experimental endpoint during early or GLP investigations. Efforts to increase sensitivity for arrythmogenic potential detection range from study design to monitoring conditions and analysis methods.